SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-017277
Filing Date
2010-02-26
Accepted
2010-02-25 20:15:22
Documents
11
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y03091e10vk.htm 10-K 1012041
2 EX-10.16 y03091exv10w16.htm EX-10.16 495102
3 EX-21.1 y03091exv21w1.htm EX-21.1 1511
4 EX-23.1 y03091exv23w1.htm EX-23.1 1205
5 EX-31.1 y03091exv31w1.htm EX-31.1 8022
6 EX-31.2 y03091exv31w2.htm EX-31.2 8008
7 EX-32.1 y03091exv32w1.htm EX-32.1 3305
8 EX-32.2 y03091exv32w2.htm EX-32.2 3312
9 GRAPHIC y03091y0309101.gif GRAPHIC 12964
10 GRAPHIC y03091y0309102.gif GRAPHIC 11744
11 GRAPHIC y03091y0309103.gif GRAPHIC 14201
  Complete submission text file 0000950123-10-017277.txt   1588229
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33357 | Film No.: 10635774
SIC: 2836 Biological Products, (No Diagnostic Substances)